NEW FORMULATIONS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE
    1.
    发明申请
    NEW FORMULATIONS FOR DIAGNOSIS OF ALZHEIMER'S DISEASE 审中-公开
    用于诊断阿尔茨海默病的新配方

    公开(公告)号:US20130045542A1

    公开(公告)日:2013-02-21

    申请号:US13639866

    申请日:2011-04-07

    IPC分类号: G01N33/566

    CPC分类号: G01N33/6896 G01N2333/4709

    摘要: A method of using at least one quantitative ratio of two different amyloid beta-peptides in a sample of a body fluid from a patient for determining the patient's probability of contracting Alzheimer's disease (AD) or for determining the patient's suffering from a precursor of Alzheimer's disease includes obtaining the sample of the body fluid from the patient. The at least one quantitative ratio is calculated from the two different amyloid beta-peptides from the sample. The patient's probability of contracting Alzheimer's disease (AD) or the patient's suffering from a precursor of Alzheimer's disease is calculated using the at least one quantitative ratio. The two different amyloid beta-peptides are selected from (a) Aβ(1-42), (b) Aβ(2-40) and (c) Aβ(2-42). The at least one quantitative ratio is selected from (a) Aβ(1-42)/(b) Aβ(2-40), (a) Aβ(1-42)/(c) Aβ(2-42), (b) Aβ(2-40)/(a) Aβ(1-42) and (c) Aβ(2-42)/(a) Aβ(1-42).

    摘要翻译: 在来自患者的体液样品中使用两种不同淀粉样蛋白β-肽的至少一种定量比例的方法,用于确定患者的阿尔茨海默氏病(AD)收缩的可能性或用于确定患者患有阿尔茨海默氏病的前兆 包括从患者获得体液的样品。 从样品中的两种不同淀粉样蛋白β肽计算至少一种定量比例。 使用至少一个定量比率计算患者阿尔茨海默氏病(AD)或患者患有阿尔茨海默病前兆的可能性。 两种不同的淀粉样蛋白β-肽选自(a)A&bgr;(1-42),(b)A&bgr;(2-40)和(c)A&bgr;(2-42)。 选自(a)A和Bgr(1-42)/(b)A&bgr;(2-40),(a)A&bgr;(1-42)/(c) 42),(b)A&bgr;(2-40)/(a)A&bgr;(1-42)和(c)A&bgr;(2-42)/(a)A&bgr;(1-42)。